Traphaco Joint Stock Company (code TRA – HOSE) announced consolidated financial statements for the first quarter of 2021 with high growth in revenue and profit over the same period.
Traphaco’s system of medicine blister blister machines Specifically, net revenue reached nearly 472 billion, up 20.4% over the same period, after subtracting COGS, gross profit reached 265 billion, up 21% compared to the first quarter of 2020. Profit after tax reached VND 55.3 billion, an increase of 35% compared to the same period of 2020; Parent company EAT is more than 51 billion. In 2021, Traphaco sets a double growth business plan with the goal of consolidated revenue and profit after tax of VND 2,100 billion and VND 240 billion, up 10% and 11% respectively compared to the performance of 2020. Thus, after the first quarter of the year, the Company has reached 20.8% of the revenue plan and 23% of the profit after tax plan of the year. In the period of 2021 – 2025, Traphaco expects that the growth rate of revenue and pre-tax interest can reach a compound rate of 13.3% and 15%. Traphaco also said that during this term the company will restructure the traditional and non-traditional medicine businesses, in which the company will increase the proportion of the western medicine industry. When consolidating the business segments, Traphaco believes that the growth rate will be even higher than the plan set out for the 2021 – 2025 term. At the close of the session on April 22, TRA shares increased slightly by 0.1% to VND69,900 per share.
You must log in to post a comment.